Skip to content

Clinical trials

Bone Diseases, Metabolic trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Bone Diseases, Metabolic Country / region: Italy Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20041
20051
20123
20131
20141
20152
20161
20182
20202
20212
20221
20231
20243
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13
Recruiting6
Terminated2
Unknown status2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Istituto Ortopedico Rizzoli3
GBR Academy2
ANTIMO1
Alphatec Spine, Inc.1
Amgen1
D'Albis Dental1
Eli Lilly and Company1
Ente Ospedaliero Ospedali Galliera1
Giovanni Di Perri1
I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Bone Diseases, Metabolic24
Osteoporosis8
Alveolar Bone Loss2
Neoplasms2
Osteoporosis, Postmenopausal2
Soft Tissue Infections2
Ankylosis1
Anodontia1
Bone Diseases1
Bone Resorption1

Trials

Showing 26 to 24 of 24. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.